Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma

By Spiller Susan   Ravanpay Ali   Hahn Andrew   Olson James  

Journal of Neuro-Oncology, Vol. 79, Iss. 3, 2006-09 ,pp. : 259-270

Springer Publishing Company

Access to resources Recommend Favorite

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer

By Shi Yi-kang   Li Zhong-hua   Han Xi-qian   Yi Ji-hu   Wang Zhen-hua   Hou Jing-li   Feng Cong-ran   Fang Qing-hong   Wang Hui-hui   Zhang Peng-fei   Wang Feng-shan   Shen Jie   Wang Peng  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1131-1140

Springer Publishing Company

Access to resources Recommend Favorite

The epigenetic agents suberoylanilide hydroxamic acid and 5AZA2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo

By                        

International Journal of Oncology, Vol. 46, Iss. 5, 2015-01 ,pp. : 2223-2230

Spandidos Publications

Access to resources Recommend Favorite

GSK1904529A, an insulinlike growth factor1 receptor inhibitor, inhibits glioma tumor growth, induces apoptosis and inhibits migration

By                

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3381-3385

Spandidos Publications

Access to resources Recommend Favorite

Salinomycin inhibits the tumor growth of glioma stem cells by selectively suppressing glioma-initiating cells

By                          

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2407-2412

Spandidos Publications

Access to resources Recommend Favorite